4887
SAWAI GROUP HOLDINGS Co.,Ltd.
サワイグループホールディングス
- Industry
- Pharmaceutical
- Market
- Prime
- Accounting standards
- IFRS
- Consolidation basis
- Consolidated
Notes
- Stock adjustmentsOct 1, 2024 Stock split 1 share → 3 shares
Key metrics
Revenue(million JPY)
Mar 2022
193,816
Mar 2023
200,344
Mar 2024
176,862
Mar 2025
189,024
Mar 2026
201,676
Operating profit(million JPY)
Mar 2022
-35,888
Mar 2023
16,984
Mar 2024
18,620
Mar 2025
4,050
Mar 2026
15,894
Operating profit margin(%)
Mar 2022
-18.52
Mar 2023
8.48
Mar 2024
10.53
Mar 2025
2.14
Mar 2026
7.88
Profit before tax(million JPY)
Mar 2022
-36,214
Mar 2023
16,789
Mar 2024
18,262
Mar 2025
3,161
Mar 2026
14,273
Profit(million JPY)
Mar 2022
-28,269
Mar 2023
12,667
Mar 2024
13,695
Mar 2025
11,969
Mar 2026
10,438
Total assets(million JPY)
Mar 2022
349,502
Mar 2023
364,165
Mar 2024
382,024
Mar 2025
354,623
Mar 2026
359,919
Cash and cash equivalents(million JPY)
Mar 2022
47,717
Mar 2023
33,076
Mar 2024
26,368
Mar 2025
38,785
Mar 2026
28,989
Cash flows from operating activities(million JPY)
Mar 2022
34,310
Mar 2023
13,026
Mar 2024
23,149
Mar 2025
27,851
Mar 2026
7,433
Cash flows from investing activities(million JPY)
Mar 2022
-30,395
Mar 2023
-27,134
Mar 2024
-23,112
Mar 2025
6,480
Mar 2026
-22,898
Cash flows from financing activities(million JPY)
Mar 2022
-11,262
Mar 2023
-1,267
Mar 2024
2,363
Mar 2025
-32,704
Mar 2026
5,587
Return on equity(%)
Mar 2022
-13.8
Mar 2023
6.5
Mar 2024
6.6
Mar 2025
6.2
Mar 2026
5.9
Equity ratio(%)
Mar 2022
54.4
Mar 2023
55.4
Mar 2024
55.7
Mar 2025
49
Mar 2026
49.6
Earnings per share(JPY per share)
Mar 2022
-215.1767
Mar 2023
96.4167
Mar 2024
104.2233
Mar 2025
96.54
Mar 2026
90.39
Net assets per share(JPY per share)
Mar 2022
1,446.7733
Mar 2023
1,534.89
Mar 2024
1,618.32
Mar 2025
1,505.86
Mar 2026
1,546.13
Dividend per share(JPY per share)
Mar 2022
43.3333
Mar 2023
43.3333
Mar 2024
43.3333
Mar 2025
53
Mar 2026
55
Payout ratio(%)
Mar 2022
-
Mar 2023
44.94
Mar 2024
41.58
Mar 2025
54.9
Mar 2026
60.85
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.